Javascript must be enabled to continue!
caNanoLab – A Tool To Benefit Biomedical Nanomaterials Research
View through CrossRef
AbstractThe cancer Nanotechnology Laboratory Web portal ("http://cananolab.nci.nih.gov/caNanoLab/welcome.do":http://cananolab.nci.nih.gov/caNanoLab/welcome.do) is designed to promote sharing of nanomedicine data and to provide support for the annotation of nanoparticles with information about their composition, function, and characterization. The project is a part of NCI cancer Biomedical Informatics Grid (caBIG®), and includes a collaboration among the NCI Center for Biomedical Informatics and Information Technology (CBIIT), the NCI Nanotechnology Characterization Laboratory (NCL), and the NCI Alliance for Nanotechnology.Currently, caNanolab contains nanomaterial data of 765 "public" samples. 18 samples were contributed by National Characterization Lab (USA), while the remaining 747 were submitted by a curator at Washington University in St. Louis from 114 publications. The curated samples include simple nanoparticles, such as emulsions, metal oxides, nanohorns, nanorods, polymers, quantum dots, as well as complex particles, such as dendriworms, which are conjugates of crosslinked dextran-coated iron oxide particles and dendrimers. Data submission involves curation of sample composing elements, their function (imaging, targeting, therapeutic), physico-chemical (size, molecular weight, surface/zeta potential, etc.) properties, and in vitro (cytotoxicity, blood contact,targeting/gene expression, etc.) characterizations, based on information provided in corresponding publications or obtained from the authors.caNanoLab also contributes to and utilizes resources of NanoParticle Ontology("http://www.nano-ontology.org":http://www.nano-ontology.org).
Title: caNanoLab – A Tool To Benefit Biomedical Nanomaterials Research
Description:
AbstractThe cancer Nanotechnology Laboratory Web portal ("http://cananolab.
nci.
nih.
gov/caNanoLab/welcome.
do":http://cananolab.
nci.
nih.
gov/caNanoLab/welcome.
do) is designed to promote sharing of nanomedicine data and to provide support for the annotation of nanoparticles with information about their composition, function, and characterization.
The project is a part of NCI cancer Biomedical Informatics Grid (caBIG®), and includes a collaboration among the NCI Center for Biomedical Informatics and Information Technology (CBIIT), the NCI Nanotechnology Characterization Laboratory (NCL), and the NCI Alliance for Nanotechnology.
Currently, caNanolab contains nanomaterial data of 765 "public" samples.
18 samples were contributed by National Characterization Lab (USA), while the remaining 747 were submitted by a curator at Washington University in St.
Louis from 114 publications.
The curated samples include simple nanoparticles, such as emulsions, metal oxides, nanohorns, nanorods, polymers, quantum dots, as well as complex particles, such as dendriworms, which are conjugates of crosslinked dextran-coated iron oxide particles and dendrimers.
Data submission involves curation of sample composing elements, their function (imaging, targeting, therapeutic), physico-chemical (size, molecular weight, surface/zeta potential, etc.
) properties, and in vitro (cytotoxicity, blood contact,targeting/gene expression, etc.
) characterizations, based on information provided in corresponding publications or obtained from the authors.
caNanoLab also contributes to and utilizes resources of NanoParticle Ontology("http://www.
nano-ontology.
org":http://www.
nano-ontology.
org).
Related Results
caNanoLab: enhancing retrieval and sharing of cancer nanotechnology data
caNanoLab: enhancing retrieval and sharing of cancer nanotechnology data
The US National Cancer Institute (NCI) cancer Nanotechnology Laboratory (
caNanoLab
) data portal is an online nanomaterial database that allows...
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
Optimising tool wear and workpiece condition monitoring via cyber-physical systems for smart manufacturing
Optimising tool wear and workpiece condition monitoring via cyber-physical systems for smart manufacturing
Smart manufacturing has been developed since the introduction of Industry 4.0. It consists of resource sharing and networking, predictive engineering, and material and data analyti...
Genotoxicity Induced By Nanomaterials
Genotoxicity Induced By Nanomaterials
Abstract
Nanomaterials are useful for their characteristic properties and are commonly used in various fields. The assessment of genotoxicity and safety of nanoma...
Nanomaterials: Synthesis and Applications in Theranostics
Nanomaterials: Synthesis and Applications in Theranostics
Nanomaterials are endowed with unique features and essential properties suitable for employing in the field of nanomedicine. The nanomaterials can be classified as 0D, 1D, 2D, and ...
Advances of hafnium based nanomaterials for cancer theranostics
Advances of hafnium based nanomaterials for cancer theranostics
Hafnium-based nanomaterials (Hf-NMs) have attracted the interest of numerous biomedical researchers by their unique properties. Recent years have witnessed significant advancements...

